The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
TGF-β1 Prevents the Noncognate Maturation of Human Dendritic Langerhans Cells
Abstract
TGF-β1 is critical for differentiation of epithelial-associated dendritic Langerhans cells (LC). In accordance with the characteristics of in vivo LC, we show that LC obtained from human monocytes in vitro in the presence of TGF-β1 1) express almost exclusively intracellular class II Ags, low CD80, and no CD83 and CD86 Ags and 2) down-regulate TNF-RI (p55) and do not produce IL-10 after stimulation, in contrast to dermal dendritic cells and monocyte-derived dendritic cells. Surprisingly, while LC exhibit E-cadherin down-regulation upon exposure to TNF-α and IL-1, TGF-β1 prevents the final LC maturation in response to TNF-α, IL-1, and LPS with respect to Class II CD80, CD86, and CD83 Ag expression, loss of FITC-dextran uptake, production of IL-12, and Ag presentation. In sharp contrast, CD40 ligand cognate signal induces full maturation of LC and is not inhibited by TGF-β1. The presence of emigrated immature LCs in human reactive skin-draining lymph nodes provides in vivo evidence that LC migration and final maturation may be differentially regulated. Therefore, due to the effects of TGF-β1, inflammatory stimuli may not be sufficient to induce full maturation of LC, thus avoiding potentially harmful immune responses. We conclude that TGF-β1 appears to be responsible for both the acquisition of LC phenotype, cytokine production pattern, and prevention of noncognate maturation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
Sallusto, F., Cella, M., Danieli, C., & Lanzavecchia, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.389 · Cited by 2,500
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,092
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., & Alber, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.747 · Cited by 1,983
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Proliferating dendritic cell progenitors in human blood.
Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., & Schuler, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.83 · Cited by 1,840
High gradient magnetic cell separation with MACS
Miltenyi, S., Müller, W., Weichel, W., & Radbruch, A. (1990) · Cytometry · doi:10.1002/cyto.990110203 · Cited by 1,681
Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response
Hart, D. N. J. (1997) · Blood · doi:10.1182/blood.v90.9.3245 · Cited by 1,483
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
Cella, M., Engering, A., Pinet, V., Pieters, J., & Lanzavecchia, A. (1997) · Nature · doi:10.1038/42030 · Cited by 1,123
The Duration of Antigenic Stimulation Determines the Fate of Naive and Effector T Cells
Iezzi, G., Karjalainen, K., & Lanzavecchia, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80461-6 · Cited by 908
Developmental regulation of MHC class II transport in mouse dendritic cells
Pierre, P., Turley, S. J., Gatti, E., Hull, M., Meltzer, J., Mirza, A., Inaba, K., Steinman, R. M., & Mellman, I. (1997) · Nature · doi:10.1038/42039 · Cited by 746
Migration and maturation of Langerhans cells in skin transplants and explants.
Larsen, C. P., Steinman, R. M., Witmer-Pack, M., Hankins, D. F., Morris, P. J., & Austyn, J. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.5.1483 · Cited by 648
Witmer-Pack, M. D., Olivier, W., Valinsky, J., Schuler, G., & Steinman, R. M. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1484 · Cited by 506
Geissmann (1998) · doi:10.1084/jem.187.6.961 · Cited by 501
Borkowski, T. A., Letterio, J. J., Farr, A. G., & Udey, M. C. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2417 · Cited by 474
Roake, J. A., Rao, A. S., Morris, P. J., Larsen, C. P., Hankins, D. F., & Austyn, J. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2237 · Cited by 464
de Saint-Vis, B., Fugier-Vivier, I., Massacrier, C., Gaillard, C., Vanbervliet, B., Aït-Yahia, S., Banchereau, J., Liu, Y.-J., Lebecque, S., & Caux, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1666 · Cited by 427
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Durand, I., Cella, M., Lanzavecchia, A., & Banchereau, J. (1997) · Blood · doi:10.1182/blood.v90.4.1458 · Cited by 424
Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
Garrone, P., Neidhardt, E. M., Garcia, E., Galibert, L., van Kooten, C., & Banchereau, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1265 · Cited by 390
The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.
Roy, M., Waldschmidt, T., Aruffo, A., Ledbetter, J. A., & Noelle, R. J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2497 · Cited by 366
Nestle, F. O., Zheng, X. G., Thompson, C. B., Turka, L. A., & Nickoloff, B. J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6535 · Cited by 366
Carlsson, S. R., Roth, J., Piller, F., & Fukuda, M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37369-1 · Cited by 345
Langerhans cells require signals from both tumour necrosis factor‐α and interleukin‐1β for migration
CUMBERBATCH, M., DEARMAN, R. J., & KIMBER, I. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00360.x · Cited by 334
TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors
Strobl, H., Riedl, E., Scheinecker, C., Bello-Fernandez, C., Pickl, W. F., Rappersberger, K., Majdic, O., & Knapp, W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1499 · Cited by 300
Strobl, H., Bello-Fernandez, C., Riedl, E., Pickl, W. F., Majdic, O., Lyman, S. D., & Knapp, W. (1997) · Blood · doi:10.1182/blood.v90.4.1425 · Cited by 194
Kang, K., Hammerberg, C., Meunier, L., & Cooper, K. D. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.5256 · Cited by 190
KRISTENSEN, M., CHU, C. Q., EEDY, D. J., FELDMANN, M., BRENNAN, F. M., & BREATHNACH, S. M. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb03457.x · Cited by 171
Jakob, T., & Udey, M. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.4067 · Cited by 163
WANG, B., Fujisawa, H., Zhuang, L., Kondo, S., Shivji, G. M., Kim, C. S., Mak, T. W., & Sauder, D. N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.12.6148 · Cited by 153
Borkowski, T. A., Letterio, J. J., Mackall, C. L., Saitoh, A., Wang, X., Roop, D. R., GRESS, R. E., & Udey, M. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119567 · Cited by 121
Ceramide Inhibits Antigen Uptake and Presentation by Dendritic Cells
Sallusto, F., Nicolò, C., Maria, R. D., Corinti, S., & Testi, R. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2411 · Cited by 99
Kang, K., Gilliam, A. C., Chen, G., Tootell, E., & Cooper, K. D. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00121.x · Cited by 98
Jakob, T., Saitoh, A., & Udey, M. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.6.2693 · Cited by 42
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
Antigen Presentation and T Cell Stimulation by Dendritic Cells
Guermonprez, P., Valladeau, J., Zitvogel, L., Théry, C., & Amigorena, S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064828 · Cited by 1,926
Self-citationCytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1208 · Cited by 1,604
Metadata
- Authors
- Geissmann, F., Revy, P., Regnault, A., Lepelletier, Y., Dy, M., Brousse, N., Amigorena, S., Hermine, O., & Durandy, A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-04
- Volume
- 162
- Issue
- 8
- Pages
- 4567-4575
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W4313377040
- Cited by
- 333
- References
- 39
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.